LPA Scientific Advisory Board
MISSION: The Laboratory Products Association (LPA) will present laboratory leaders through its newly created Scientific Advisory Board. The primary purpose of the LPA Scientific Advisory Board is to seek the expertise of those in the lab to enhance the knowledge, understanding, and strategic thinking of laboratories for LPA members, as well as provide a live forum for LPA members to tap into for insight on trends in the lab, ask questions about the lab of the future, etc.
LPA Scientific Advisory Board panel
Biotech & Biopharma Research: New Trends & Workflows in Drug Discovery
View the handouts here: www.lpanet.org/handouts
____________________________________________________________
The LPA Scientific Advisory Board - Past Sessions
View the recordings from past events at www.lpanet.org/handouts
The LPA Scientific Advisory Board held the latest session on BioPharma and Biotech Workflows - Today and Tomorrow, with moderator Hamid Ghanadan and five panelists who are principal investigators with large and small BioPharma/Biotech labs. Panelists discussed their lab workflows as well as other topics such as how the pandemic and supply chain are impacting their labs, market forces, and purchasing processes and supplier interaction preferences. You can watch or listen to the recording by going to Meeting Handouts.
The LPA Scientific Advisory Board Academic Labs Outlook welcomed back several lab leaders to share their insights and perspectives on a range of questions surrounding supply chain solutions, changes in purchasing behaviors, specific cost increases, delivery of goods impacts, and desired labs of the future. With over 170 registered attendees, it is without a doubt that the Scientific Advisory Board sessions are of great value to our members. You can watch or listen to the recording by going to Meeting Handouts.
The LPA Scientific Advisory Board's second session, Cannabis Labs Outlook, was held on October 6 and it had three active panelists, as well as comments from another, as well as moderator, Julia Bramante, Lead Scientist at the Cannabis Reference Laboratory, Colorado Department of Public Health. Panelists included Brittaney Dowd, Chief Chemist at Dragonfly Processing; Stephen Goldman, Chief Science Officer for Kaycha Labs; and Saman Razani, Founder and Chief Executive Officer of SZN Partners. The agenda and questions asked can be found here. The session was recorded and can be found in the handouts section of members' only resources.
The LPA held its inaugural Scientific Advisory Board session, Engaging the Lab of 2022 in a Post-COVID Environment on April 21 and it was a big success! Scripted and moderated by Scott Hanton, Editorial Director for Lab Manager. Over 130 LPA members joined in to listen to lab leaders from Indiana State University, Madonna University, Duke University, University of Michigan, and University of Miami share their insights and perspectives on a range of questions. These included: how open is your institution’s lab; in a post-pandemic world, will there be rigid appointment adherence for seeing vendors; as you look at how you purchase, how will pricing negotiation take place going forward; as a result of the pandemic, what changes in funding trends/patterns do you see for your institution’s lab going forward; and more. The session was recorded and can be found in the handouts section of members' only resources.
The LPA Scientific Advisory Board was created by the Market Data Committee, chaired by Harry Ruska. Visit www.lpanet.org/committees and find out how you can contribute to your industry association!
Visit www.lpanet.org/handouts for full zoom recordings of past LPA events.
